Skip to main content

Table 1 Data extracted from electronic medical records and archives

From: Health-related quality of life and burden of illness in adults with newly diagnosed attention-deficit/hyperactivity disorder in Sweden

Basic characteristics

Age, sex, type of referral, confirmed ADHD diagnosis, other psychiatric diagnoses (confirmed using MINI)

Social status

Marital status, parental status (biological), age of children, housing, education, main source of income

Patient history

Psychiatric history, previous confirmed psychiatric diagnoses, current registered somatic diagnoses

Family history

General and specific psychiatric and neuropsychiatric disorders in the family

Risk assessment

Previous suicide attempts, previous or current self-destructive, aggressive, or criminal behaviour

ADHD diagnostic interview

DIVA 2.0 (symptoms of attention deficit [A1] and hyperactivity/impulsivity [A2])

Patient-reported measures

Scores for ASRS-v.1.1 Screener and Symptom checklist and AUDIT, DUDIT, MADRS-S, and EQ-5D

Intelligence assessment

WAIS-IV score

Pharmacological treatments

Current psychiatric and somatic medications, recommended ADHD medication after neuropsychiatric investigation

  1. ADHD attention-deficit/hyperactivity disorder, ASRS-v.1.1 Adult ADHD Self-Report Scale version 1.1, AUDIT Alcohol Use Disorders Identification Test, DIVA 2.0 Diagnostic Interview for ADHD in Adults, second edition, DUDIT Drug Use Disorders Identification Test, EQ-5D five-dimension EuroQol questionnaire, MADRS-S Montgomery–Åsberg Depression Rating Scale – Self-reported, MINI Mini International Neuropsychiatric Interview, WAIS-IV Wechsler Adult Intelligence Scale IV